Sulphadoxine/pyrimethamine: an appropriate first-line alternative for the treatment of uncomplicated falciparum malaria in Ghanaian children under 5 years of age
- 1 July 2002
- journal article
- clinical trial
- Published by Wiley in Tropical Medicine & International Health
- Vol. 7 (7) , 577-583
- https://doi.org/10.1046/j.1365-3156.2002.00910.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Making malaria treatment policy in the face of drug resistancePathogens and Global Health, 1999
- Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub‐Saharan AfricaTropical Medicine & International Health, 1998
- Plasmodium falciparum: susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanaian schoolchildrenTransactions of the Royal Society of Tropical Medicine and Hygiene, 1994
- Beyond Chloroquine: Implications of Drug Resistance for Evaluating Malaria Therapy Efficacy and Treatment Policy in AfricaThe Journal of Infectious Diseases, 1993
- The role of shops in the treatment and prevention of childhood malaria on the coast of KenyaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1992
- Plasmodium falciparum: sensitivity to chloroquine in vivo in three ecological zones in GhanaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1992
- Treatment of Chioroquine-Resistant Malaria in African Children: A Cost-Effectiveness AnalysisInternational Journal of Epidemiology, 1992
- Why we seek treatment here: Retail pharmacy and clinical practice in Maiduguri, NigeriaSocial Science & Medicine, 1987
- IN VIVO CHLOROQUINE-RESISTANT FALCIPARUM MALARIA IN WESTERN AFRICAThe Lancet, 1986
- CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM EAST AFRICA:The Lancet, 1979